Institute of Physiology, Medical Faculty, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany.
Center for Behavioral Brain Sciences (CBBS), 39120 Magdeburg, Germany.
Int J Mol Sci. 2021 Jan 30;22(3):1378. doi: 10.3390/ijms22031378.
Alzheimer's disease (AD) is a multifaceted neurodegenerative disorder characterized by progressive and irreversible cognitive decline, with no disease-modifying therapy until today. Spike timing-dependent plasticity (STDP) is a Hebbian form of synaptic plasticity, and a strong candidate to underlie learning and memory at the single neuron level. Although several studies reported impaired long-term potentiation (LTP) in the hippocampus in AD mouse models, the impact of amyloid-β (Aβ) pathology on STDP in the hippocampus is not known. Using whole cell patch clamp recordings in CA1 pyramidal neurons of acute transversal hippocampal slices, we investigated timing-dependent (t-) LTP induced by STDP paradigms at Schaffer collateral (SC)-CA1 synapses in slices of 6-month-old adult APP/PS1 AD model mice. Our results show that t-LTP can be induced even in fully developed adult mice with different and even low repeat STDP paradigms. Further, adult APP/PS1 mice displayed intact t-LTP induced by 1 presynaptic EPSP paired with 4 postsynaptic APs (6× 1:4) or 1 presynaptic EPSP paired with 1 postsynaptic AP (100× 1:1) STDP paradigms when the position of Aβ plaques relative to recorded CA1 neurons in the slice were not considered. However, when Aβ plaques were live stained with the fluorescent dye methoxy-X04, we observed that in CA1 neurons with their somata <200 µm away from the border of the nearest Aβ plaque, t-LTP induced by 6× 1:4 stimulation was significantly impaired, while t-LTP was unaltered in CA1 neurons >200 µm away from plaques. Treatment of APP/PS1 mice with the anti-inflammatory drug fingolimod that we previously showed to alleviate synaptic deficits in this AD mouse model did not rescue the impaired t-LTP. Our data reveal that overexpression of APP and PS1 mutations in AD model mice disrupts t-LTP in an Aβ plaque distance-dependent manner, but cannot be improved by fingolimod (FTY720) that has been shown to rescue conventional LTP in CA1 of APP/PS1 mice.
阿尔茨海默病(AD)是一种多方面的神经退行性疾病,其特征是进行性和不可逆转的认知能力下降,直到今天仍没有针对该疾病的治疗方法。尖峰时间依赖可塑性(STDP)是一种赫布式突触可塑性形式,是在单个神经元水平上进行学习和记忆的有力候选者。尽管几项研究报告称 AD 小鼠模型的海马体中长时程增强(LTP)受损,但尚不清楚淀粉样蛋白-β(Aβ)病理学对海马体中 STDP 的影响。我们使用急性横切海马脑片的 CA1 锥体神经元全细胞膜片钳记录,在 APP/PS1 AD 模型小鼠的海马脑片中,我们在 Schaffer 侧支(SC)-CA1 突触处,用 STDP 范式诱导的时间依赖性(t-)LTP。我们的结果表明,即使在具有不同且甚至低重复 STDP 范式的完全发育的成年小鼠中,也可以诱导 t-LTP。此外,当不考虑切片中记录的 CA1 神经元相对于 Aβ 斑块的位置时,成年 APP/PS1 小鼠显示出由 1 个突触前 EPSP 与 4 个突触后 AP 配对(6×1:4)或 1 个突触前 EPSP 与 1 个突触后 AP 配对(100×1:1)STDP 范式诱导的完整 t-LTP。然而,当用荧光染料甲氧基-X04 对 Aβ 斑块进行活体染色时,我们观察到在距最近 Aβ 斑块边界<200µm 的 CA1 神经元中,由 6×1:4 刺激诱导的 t-LTP 显著受损,而在距斑块>200µm 的 CA1 神经元中,t-LTP 未改变。我们之前曾表明,抗炎药物 fingolimod 可减轻 AD 小鼠模型中的突触缺陷,用这种药物治疗 APP/PS1 小鼠并不能挽救受损的 t-LTP。我们的数据表明,AD 模型小鼠中 APP 的过度表达和 PS1 突变以 Aβ 斑块距离依赖的方式破坏 t-LTP,但不能通过 fingolimod(FTY720)改善,fingolimod 已被证明可挽救 APP/PS1 小鼠 CA1 中的常规 LTP。